- Mason Scientists Develop COVID-19 Antibody Measurement Technology to Rapidly Assess Virus Blocking Efficacy
by Tracy Mason A cross-disciplinary team coordinated by scientists at Mason’s Center for Infectious Disease Research (CIDR), led by Yuntao Wu, Professor, School of Systems Biology, have […] - DOD funds Mason Scientists’ breakthrough breast cancer prevention and treatment researchby Laura Powers George Mason University College of Science announced a $1.57 million dollar grant from the Department of Defense to fund a transformative approach […]
- Mason Science Trailblazer: Charles L. Bailey
by Tracy Mason Charles (Charlie) Bailey retired effective February 1, 2022, having experienced an illustrious career as a visionary biodefense researcher and scientific trailblazer for George […] - Dr. Ramin M. Hakami, and three SSB Graduate Students, Have Research Article Published in Cell & Bioscience“Congratulations to three SSB graduate students in Dr. Hakami’s laboratory, Adeyemi Olanrewaju, Samson Omole, and Graham Matulis, for their important contributions to a main research article […]
- Andalibi and Alem receive funding for facility and building system upgrades support for Mason Biomedical Research LaboratoryNov 15, 2021 by Elizabeth Grisham Ali Andalibi, Senior Associate Dean, College of Science, and Farhang Alem, Research Scientist, Center for Infectious Disease Research (formerly NCBID), Assistant Director of […]
- Hakami developing stable cell line for production of exosomes carrying EIAV GP90 glycoprotein for vaccine development“Ramin Hakami, Associate Professor, School of Systems Biology, and researchers in his lab are purifying exosomes from the EIAV-gp90 cell line. They are doing so to demonstrate that exosomes have gp90 on the surface and […]
- Mason scientists explore herbal treatment for COVID-19“Could an over-the-counter health “shot” help fight COVID-19? George Mason University researchers think it just might. Cell and Bioscience recently highlighted research led by Yuntao Wu and Ramin Hakami, […]
- Yuntao Wu and Ramin Hakami investigating COVID-19 therapiesFor full article, click here
- Noble Life Sciences to Conduct Research on Mason SciTech Campus in Collaboration Agreement with National Center for Biodefense and Infectious DiseasesFor full article, click here
- Innovation Pharmaceuticals and George Mason University Release Laboratory Testing Results Demonstrating Brilacidin’s COVID-19 Treatment PotentialFor full article, click here
News & Events
- Home
- /
- News & Events